Hubei Key Laboratory of Industrial Microbiology, Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068 China.
Hubei Key Laboratory of Industrial Microbiology, Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068 China.
Eur J Med Chem. 2018 Oct 5;158:951-964. doi: 10.1016/j.ejmech.2018.09.022. Epub 2018 Sep 14.
4'-Demethylepipodophyllotoxin (DMEP) derivatives are broad-spectrum and potent antitumor leading compound. Because of their unacceptable toxicity, DMEP derivatives often failed in the development of new drug. Until now, there was no report on the millimolar-potency toxicity of DMEP derivatives by modifying the molecule structure of DMEP. For the first time, this work discovered leading compounds with millimolar-potency toxicity by modifying the molecule structure of DMEP. The IC value of 4β-S-(5-fluorobenzoxazole-2-)-4-deoxy-4'-demethylepipodophyllotoxin (Compound 2) was around 323.4-2000.9 μM on human healthy cells (i.e., HL-7702, H8, MRC-5 and HMEC), which was significantly reduced by 171-1999 times than podophyllotoxin (1.0-2.6 μM) and 9-80 times than etoposide (21.5-75.4 μM). Compared with the treatment of etoposide, DNA repair proteins HMGB1 and PARK7 were specifically activated and the expression of anti-apoptotic proteins were up-regulated in HL-7702 cells after the treatment of Compound 2. These indicated the toxicity of Compound 2 was synergistically reduced by DNA repair and anti-apoptosis pathway.
4'-去甲表鬼臼毒素(DMEP)衍生物是一种广谱且强效的抗肿瘤先导化合物。由于其不可接受的毒性,DMEP 衍生物在新药开发中经常失败。到目前为止,还没有关于通过修饰 DMEP 分子结构来获得具有毫摩尔效力毒性的 DMEP 衍生物的报道。本工作首次通过修饰 DMEP 的分子结构发现了具有毫摩尔效力毒性的先导化合物。4β-S-(5-氟苯并恶唑-2-)-4-去氧-4'-去甲表鬼臼毒素(化合物 2)对人正常细胞(HL-7702、H8、MRC-5 和 HMEC)的 IC 值约为 323.4-2000.9μM,比鬼臼毒素(1.0-2.6μM)降低了 171-1999 倍,比依托泊苷(21.5-75.4μM)降低了 9-80 倍。与依托泊苷处理相比,在 HL-7702 细胞中,化合物 2 处理后特异性激活 DNA 修复蛋白 HMGB1 和 PARK7,并上调抗凋亡蛋白的表达。这些表明化合物 2 的毒性通过 DNA 修复和抗凋亡途径协同降低。